Materials • Major Chemicals
$6.25 ▼ -0.22
(-3.40%)
MKT CAP: $79.8M • VOL: 1.4K
52W L $5 52W H $9
FSI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $38.5M | $38.2M | $38.3M |
| YoY Revenue Growth % | +0.7% | -0.2% | — |
| Gross Profit | $12.5M | $13.2M | — |
| Gross Margin % | 32.6% | 34.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.6M | $5.5M | $3.5M |
| Operating Margin % | 11.9% | 14.4% | 9.1% |
| Net Income (GAAP) | $786.9K | $3.0M | $2.8M |
| EBITDA (Normalized) | $8.1M | $9.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.8M | $5.6M | $6.1M |
| Capital Expenditures (CapEx) | $4.4M | $5.0M | — |
| Free Cash Flow (FCF) | -$591.7K | $603.6K | $6.1M |
| FCF Margin % | -1.5% | 1.6% | 16.0% |
| Return on Invested Capital (ROIC %) | 8.5% | 11.8% | — |
| Cash & Short-Term Equivalents | — | $7.6M | — |
| Total Debt (Short + Long Term) | $4.0M | $6.6M | — |
| Total Stockholders' Equity | $38.9M | $38.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FSI.